{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T12:30:29Z","timestamp":1791721829283,"version":"4.3.4"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-025-02679-1","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T11:26:00Z","timestamp":1756207560000},"page":"2831-2843","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Lowering the dexamethasone suppression test cut-off: is it time yet?"],"prefix":"10.1007","volume":"48","author":[{"given":"Vittoria","family":"Favero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Eller-Vainicher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Morelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Scillitani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7594-3300","authenticated-orcid":false,"given":"Iacopo","family":"Chiodini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,26]]},"reference":[{"issue":"5","key":"2679_CR1","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1210\/jc.2008-0125","volume":"93","author":"LK Nieman","year":"2008","unstructured":"Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM, Montori VM (2008) The diagnosis of Cushing\u2019s syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 93(5):1526\u20131540. https:\/\/doi.org\/10.1210\/jc.2008-0125","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2679_CR2","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1093\/ejendo\/lvad066","volume":"189","author":"M Fassnacht","year":"2023","unstructured":"Fassnacht M, Tsagarakis S, Terzolo M, Tabarin A, Sahdev A, Newell-Price J et al (2023) European society of endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European network for the study of adrenal tumors. Eur J Endocrinol 189(1):G1\u201342","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"2679_CR3","doi-asserted-by":"publisher","first-page":"3331","DOI":"10.1210\/clinem\/dgab512","volume":"106","author":"I Bancos","year":"2021","unstructured":"Bancos I, Prete A (2021) Approach to the patient with adrenal incidentaloma. J Clin Endocrinol Metab 106(11):3331\u20133353","journal-title":"J Clin Endocrinol Metab"},{"key":"2679_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2021.101521","author":"OA Hakami","year":"2021","unstructured":"Hakami OA, Ahmed S, Karavitaki N (2021) Epidemiology and mortality of Cushing\u2019s syndrome. Best Pract Res Clin Endocrinol Metab. https:\/\/doi.org\/10.1016\/j.beem.2021.101521","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"2","key":"2679_CR5","first-page":"440","volume":"84","author":"C Invitti","year":"1999","unstructured":"Invitti C, Giraldi FP, De Martin M, Cavagnini F (1999) Diagnosis and management of cushing\u2019s syndrome: results of an Italian multicentre study. Study group of the Italian society of endocrinology on the pathophysiology of the Hypothalamic-Pituitary-Adrenal axis. J Clin Endocrinol Metab 84(2):440\u2013448","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2679_CR6","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/0026-0495(79)90097-0","volume":"28","author":"L Crapo","year":"1979","unstructured":"Crapo L (1979) Cushing\u2019s syndrome: a review of diagnostic tests. Metabolism 28(9):955\u2013977","journal-title":"Metabolism"},{"issue":"12","key":"2679_CR7","doi-asserted-by":"publisher","first-page":"5593","DOI":"10.1210\/jc.2003-030871","volume":"88","author":"G Arnaldi","year":"2003","unstructured":"Arnaldi G, Angeli A, Atkinson AB, Bertagna X, Cavagnini F, Chrousos GP, Fava GA, Findling JW, Gaillard RC, Grossman AB, Kola B, Lacroix A, Mancini T, Mantero F, Newell-Price J, Nieman LK, Sonino N, Vance ML, Giustina A, Boscaro M (2003) Diagnosis and complications of Cushing\u2019s syndrome: a consensus statement. J Clin Endocrinol Metab 88(12):5593\u20135602","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2679_CR8","doi-asserted-by":"publisher","first-page":"E3723","DOI":"10.1210\/clinem\/dgac379","volume":"107","author":"LT Braun","year":"2022","unstructured":"Braun LT, Vogel F, Zopp S, Marchant Seiter T, Rubinstein G, Berr CM et al (2022) Whom Should We Screen for Cushing Syndrome? The Endocrine Society Practice Guideline Recommendations 2008 Revisited. J Clin Endocrinol Metab 107(9):E3723\u2013E3730","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2679_CR9","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1210\/jc.2010-2722","volume":"96","author":"I Chiodini","year":"2011","unstructured":"Chiodini I (2011) Clinical review: diagnosis and treatment of subclinical hypercortisolism. J Clin Endocrinol Metab 96(5):1223\u20131236","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2679_CR10","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1093\/ejendo\/lvae127","volume":"191","author":"LT Braun","year":"2024","unstructured":"Braun LT, Vogel F, Nowak E, Rubinstein G, Zopp S, Ritzel K et al (2024) Frequency of clinical signs in patients with Cushing\u2019s syndrome and mild autonomous cortisol secretion: overlap is common. Eur J Endocrinol 191(4):473\u2013479","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2679_CR11","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1093\/ejendo\/lvad069","volume":"189","author":"D Li","year":"2023","unstructured":"Li D, Zhang CD, Saini J, Singh S, Nathani R, Thangamuthu K et al (2023) Determinants of muscle function and health-related quality of life in patients with endogenous hypercortisolism: a cross-sectional study. Eur J Endocrinol 189(1):40\u201349","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2679_CR12","doi-asserted-by":"publisher","first-page":"e623","DOI":"10.1210\/clinem\/dgad560","volume":"109","author":"V Favero","year":"2024","unstructured":"Favero V, Eller-Vainicher C, Morelli V, Cairoli E, Salcuni AS, Scillitani A et al (2024) Increased risk of vertebral fractures in patients with mild autonomous cortisol secretion. J Clin Endocrinol Metab 109(2):e623\u2013e632","journal-title":"J Clin Endocrinol Metab"},{"key":"2679_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2021.101494","author":"C Aresta","year":"2021","unstructured":"Aresta C, Favero V, Morelli V, Giovanelli L, Parazzoli C, Falchetti A et al (2021) Cardiovascular complications of mild autonomous cortisol secretion. Best Pract Res Clin Endocrinol Metab. https:\/\/doi.org\/10.1016\/j.beem.2021.101494","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"8","key":"2679_CR14","doi-asserted-by":"publisher","first-page":"533","DOI":"10.7326\/M16-0547","volume":"165","author":"D Lopez","year":"2016","unstructured":"Lopez D, Luque-Fernandez MA, Steele A, Adler GK, Turchin A, Vaidya A (2016) Nonfunctional adrenal tumors and the risk for incident diabetes and cardiovascular outcomes: a cohort study. Ann Intern Med 165(8):533\u2013542","journal-title":"Ann Intern Med"},{"issue":"1","key":"2679_CR15","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1507\/endocrj.43.79","volume":"43","author":"J Tobinaga","year":"1996","unstructured":"Tobinaga J, Imai T, Funahashi H, Tanaka Y, Wada M, Morita T, Yamada F, Tsukamura K, Oiwa M, Kikumori T, Sasano H, Takagi H (1996) Incidentally discovered adrenocortical adenomas are not fully nonfunctioning: immunohistochemical and dispersed adrenocortical cell study. Endocr J 43(1):79\u201386","journal-title":"Endocr J"},{"issue":"1","key":"2679_CR16","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1530\/EJE-09-0775","volume":"162","author":"C Eller-Vainicher","year":"2010","unstructured":"Eller-Vainicher C, Morelli V, Salcuni AS, Torlontano M, Coletti F, Iorio L et al (2010) Post-surgical hypocortisolism after removal of an adrenal incidentaloma: is it predictable by an accurate endocrinological work-up before surgery? Eur J Endocrinol 162(1):91\u201399","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"2679_CR17","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1007\/s40618-023-02283-1","volume":"47","author":"I Bonaventura","year":"2024","unstructured":"Bonaventura I, Tomaselli A, Angelini F, Ferrari D, De Alcubierre D, Hasenmajer V et al (2024) Predicting postoperative hypocortisolism in patients with non-aldosterone-producing adrenocortical adenoma: a retrospective single-centre study. J Endocrinol Invest 47(7):1751\u20131762","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"2679_CR18","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/cen.13145","volume":"86","author":"SH Lee","year":"2017","unstructured":"Lee SH, Song KH, Kim J, Park S, Ahn SH, Kim H et al (2017) New diagnostic criteria for subclinical hypercortisolism using postsurgical hypocortisolism: the co-work of adrenal research study. Clin Endocrinol (Oxf) 86(1):10\u201318","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"2679_CR19","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1111\/cen.13822","volume":"89","author":"EM Ribeiro Cavalari","year":"2018","unstructured":"Ribeiro Cavalari EM, de Paula MP, Arruda M, Carraro N, Martins A, de Souza K et al (2018) Nonfunctioning adrenal incidentaloma: a novel predictive factor for metabolic syndrome. Clin Endocrinol 89(5):586\u2013595","journal-title":"Clin Endocrinol"},{"issue":"2","key":"2679_CR20","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/cen.14811","volume":"98","author":"M Araujo-Castro","year":"2023","unstructured":"Araujo-Castro M, Casals G, Hanzu FA, Pascual-Corrales E, Garc\u00eda Cano AM, Lanza VF et al (2023) Characterisation of the urinary steroid profile of patients with nonfunctioning adrenal incidentalomas: a matched controlled cross-sectional study. Clin Endocrinol (Oxf) 98(2):165\u2013176","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"9","key":"2679_CR21","doi-asserted-by":"publisher","first-page":"3529","DOI":"10.1210\/JC.2015-1992","volume":"100","author":"G Di Dalmazi","year":"2015","unstructured":"Di Dalmazi G, Fanelli F, Mezzullo M, Casadio E, Rinaldi E, Garelli S et al (2015) Steroid profiling by LC-MS\/MS in nonsecreting and subclinical cortisol-secreting adrenocortical adenomas. J Clin Endocrinol Metab 100(9):3529\u20133538","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2679_CR22","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3343\/alm.2020.40.4.285","volume":"40","author":"G Casals","year":"2020","unstructured":"Casals G, Hanzu FA (2020) Cortisol measurements in Cushing\u2019s syndrome: immunoassay or mass spectrometry? Ann Lab Med 40(4):285\u2013296","journal-title":"Ann Lab Med"},{"issue":"10","key":"2679_CR23","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1016\/j.metabol.2010.01.007","volume":"59","author":"M Peppa","year":"2010","unstructured":"Peppa M, Boutati E, Koliaki C, Papaefstathiou N, Garoflos E, Economopoulos T et al (2010) Insulin resistance and metabolic syndrome in patients with nonfunctioning adrenal incidentalomas: a cause-effect relationship? Metabolism 59(10):1435\u20131441","journal-title":"Metabolism"},{"issue":"3","key":"2679_CR24","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s12020-017-1439-6","volume":"58","author":"T Akkan","year":"2017","unstructured":"Akkan T, Altay M, \u00dcnsal Y, Da\u011fdeviren M, Beyan E (2017) Nonfunctioning adrenal incidentaloma affecting central blood pressure and arterial stiffness parameters. Endocrine 58(3):513\u2013520","journal-title":"Endocrine"},{"issue":"6","key":"2679_CR25","doi-asserted-by":"publisher","first-page":"662","DOI":"10.4158\/EP161713.OR","volume":"23","author":"M Kizilgul","year":"2017","unstructured":"Kizilgul M, Beysel S, Ozcelik O, Kan S, Apaydin M, Caliskan M et al (2017) Pentraxin 3 as a new cardiovascular marker in adrenal adenomas. Endocr Pract 23(6):662\u2013668","journal-title":"Endocr Pract"},{"issue":"1","key":"2679_CR26","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41371-017-0011-4","volume":"32","author":"M Arruda","year":"2017","unstructured":"Arruda M, Mello Ribeiro Cavalari E, Pessoa De Paula M, Fernandes Cordeiro De Morais F, Furtado Bilro G, Alves Coelho MC et al (2017) The presence of nonfunctioning adrenal incidentalomas increases arterial hypertension frequency and severity, and is associated with cortisol levels after dexamethasone suppression test. J Hum Hypertens 32(1):3\u201311","journal-title":"J Hum Hypertens"},{"issue":"3","key":"2679_CR27","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3109\/07435800.2013.840653","volume":"39","author":"A Arduc","year":"2014","unstructured":"Arduc A, Isik S, Ozuguz U, Tutuncu YA, Kucukler FK, Ozcan HN et al (2014) Relationship between thyroid nodules and non-functioning adrenal incidentalomas and their association with insulin resistance. Endocr Res 39(3):99\u2013104","journal-title":"Endocr Res"},{"issue":"8","key":"2679_CR28","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s40618-014-0106-5","volume":"37","author":"MM Tuna","year":"2014","unstructured":"Tuna MM, Imga NN, Do\u011fan BA, Y\u0131lmaz FM, Top\u00e7uo\u011flu C, Akbaba G et al (2014) Non-functioning adrenal incidentalomas are associated with higher hypertension prevalence and higher risk of atherosclerosis. J Endocrinol Invest 37(8):765\u2013768","journal-title":"J Endocrinol Invest"},{"issue":"12","key":"2679_CR29","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.4158\/EP-2020-0182","volume":"26","author":"JH Kim","year":"2020","unstructured":"Kim JH, Kim MJ, Lee JH, Yoon JW, Shin CS (2020) Nonfunctioning adrenal incidentalomas are not clinically silent: a longitudinal cohort study. Endocr Pract 26(12):1406\u20131415","journal-title":"Endocr Pract"},{"issue":"4","key":"2679_CR30","doi-asserted-by":"publisher","first-page":"e973","DOI":"10.1210\/clinem\/dgz284","volume":"105","author":"G Reimondo","year":"2020","unstructured":"Reimondo G, Castellano E, Grosso M, Priotto R, Puglisi S, Pia A et al (2020) Adrenal incidentalomas are tied to increased risk of diabetes: findings from a prospective study. J Clin Endocrinol Metab 105(4):e973\u2013e981","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2679_CR31","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s40618-020-01360-z","volume":"44","author":"MP de Paula","year":"2021","unstructured":"de Paula MP, Moraes AB, de Souza M das GC, Cavalari EMR, Campbell RC, Fernandes G da S et al (2021) Cortisol level after dexamethasone suppression test in patients with non-functioning adrenal incidentaloma is positively associated with the duration of reactive hyperemia response on microvascular bed. J Endocrinol Invest 44(3):609\u2013619","journal-title":"J Endocrinol Invest"},{"issue":"5","key":"2679_CR32","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1111\/cen.14861","volume":"98","author":"JFD Rebelo","year":"2023","unstructured":"Rebelo JFD, Costa JM, Junqueira FD, Fonseca A, de de O ABABS, Moraes AB et al (2023) Adrenal incidentaloma: do patients with apparently nonfunctioning mass or autonomous cortisol secretion have similar or different clinical and metabolic features? Clin Endocrinol (Oxf) 98(5):662\u2013669","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"14","key":"2679_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12144612","volume":"12","author":"M Szychli\u0144ska","year":"2023","unstructured":"Szychli\u0144ska M, Rzeczkowska M, Gontarz-Nowak K, Matuszewski W, Bandurska-Stankiewicz E (2023) Do non-functional adrenal adenomas affect metabolic profile and carotid intima-media thickness?? A single centre study from Poland. J Clin Med 12(14):4612","journal-title":"J Clin Med"},{"issue":"10","key":"2679_CR34","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1007\/s00268-009-0178-0","volume":"33","author":"Y Erbil","year":"2009","unstructured":"Erbil Y, Ozbey N, Barbaros U, Unalp HR, SalmaslIoglu A, \u00d6zarmagan S (2009) Cardiovascular risk in patients with nonfunctional adrenal incidentaloma: myth or reality? World J Surg 33(10):2099\u20132105","journal-title":"World J Surg"},{"issue":"4","key":"2679_CR35","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/BF03347083","volume":"34","author":"S Yener","year":"2011","unstructured":"Yener S, Baris M, Secil M, Akinci B, Comlekci A, Yesil S (2011) Is there an association between non-functioning adrenal adenoma and endothelial dysfunction? J Endocrinol Invest 34(4):265\u2013270","journal-title":"J Endocrinol Invest"},{"issue":"8","key":"2679_CR36","doi-asserted-by":"publisher","first-page":"2754","DOI":"10.1210\/jc.2013-4064","volume":"99","author":"II Androulakis","year":"2014","unstructured":"Androulakis II, Kaltsas GA, Kollias GE, Markou AC, Gouli AK, Thomas DA et al (2014) Patients with apparently nonfunctioning adrenal incidentalomas may be at increased cardiovascular risk due to excessive cortisol secretion. J Clin Endocrinol Metab 99(8):2754\u20132762","journal-title":"J Clin Endocrinol Metab"},{"key":"2679_CR37","doi-asserted-by":"publisher","first-page":"991","DOI":"10.12659\/MSM.897714","volume":"22","author":"M Evran","year":"2016","unstructured":"Evran M, Akku\u015f G, Bozdo\u011fan \u0130B, G\u00f6k M, Deniz A, Sert M et al (2016) Carotid intima-media thickness as the cardiometabolic risk indicator in patients with nonfunctional adrenal mass and metabolic syndrome screening. Med Sci Monit 22:991\u2013997","journal-title":"Med Sci Monit"},{"issue":"7","key":"2679_CR38","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.2174\/1871530320666200910110337","volume":"21","author":"O Akkus","year":"2020","unstructured":"Akkus O, Akkus G, Kaypakli O, Ozturk FK, Gurkan E, Bekler O et al (2020) Increased rates of coronary artery calcium score in patients with Non - Functioning adrenal incidentaloma. Endocr Metab Immune Disord Drug Targets 21(7):1319\u20131325","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"10","key":"2679_CR39","doi-asserted-by":"publisher","first-page":"2874","DOI":"10.1038\/s41440-024-01807-3","volume":"47","author":"M Parasiliti-Caprino","year":"2024","unstructured":"Parasiliti-Caprino M, Roux A, Campioni L, Procopio M, Arata S, Giannelli J et al (2024) Increased cardiometabolic risk and prevalence of ascending aorta dilation in patients with nonfunctioning adrenal incidentaloma: a retrospective propensity score-matched study. Hypertens Res 47(10):2874\u20132883","journal-title":"Hypertens Res"},{"issue":"4","key":"2679_CR40","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1007\/BF03345724","volume":"32","author":"S Yener","year":"2009","unstructured":"Yener S, Comlekci A, Akinci B, Secil M, Demir T, Ertilav S et al (2009) Non-functioning adrenal incidentalomas are associated with elevated D-dimer levels. J Endocrinol Invest 32(4):338\u2013343","journal-title":"J Endocrinol Invest"},{"issue":"6","key":"2679_CR41","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/BF03346410","volume":"31","author":"F Ermetici","year":"2008","unstructured":"Ermetici F, Dall\u2019Asta C, Malavazos A, Coman C, Morricone L, Montericcio V et al (2008) Echocardiographic alterations in patients with non-functioning adrenal incidentaloma. J Endocrinol Invest 31(6):573\u2013577","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"2679_CR42","doi-asserted-by":"publisher","DOI":"10.5812\/ijem.37635","volume":"14","author":"NN Imga","year":"2016","unstructured":"Imga NN, Elalmis OU, Tuna MM, Dogan BA, Sahin D, Berker D et al (2016) The relationship between increased epicardial fat thickness and left ventricular hypertrophy and carotid intima-media thickness in patients with nonfunctional adrenal incidentaloma. Int J Endocrinol Metab 14(3):e37635","journal-title":"Int J Endocrinol Metab"},{"issue":"5","key":"2679_CR43","first-page":"656","volume":"111","author":"G Sokmen","year":"2018","unstructured":"Sokmen G, Sahin M, Tuzun D, Sokmen A, Bolat H, Oguz A et al (2018) Assessment of subclinical cardiac alterations and atrial electromechanical delay by tissue doppler echocardiography in patients with nonfunctioning adrenal incidentaloma. Arq Bras Cardiol 111(5):656\u2013663","journal-title":"Arq Bras Cardiol"},{"issue":"3","key":"2679_CR44","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s12020-009-9160-8","volume":"35","author":"S Yener","year":"2009","unstructured":"Yener S, Genc S, Akinci B, Secil M, Demir T, Comlekci A et al (2009) Carotid intima media thickness is increased and associated with morning cortisol in subjects with non-functioning adrenal incidentaloma. Endocrine 35(3):365\u2013370","journal-title":"Endocrine"},{"issue":"4","key":"2679_CR45","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1590\/2359-3997000000053","volume":"59","author":"T Delibasi","year":"2015","unstructured":"Delibasi T, Karbek B, Bozkurt NC, Cakir E, Gungunes A, \u00dcnsal \u00d6\u00d6 et al (2015) Circulating E-selectin levels and insulin resistance are associated with early stages of atherosclerosis in nonfunctional adrenal incidentaloma. Arch Endocrinol Metab 59(4):310\u2013317","journal-title":"Arch Endocrinol Metab"},{"issue":"7","key":"2679_CR46","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.endinu.2019.01.007","volume":"66","author":"R Emral","year":"2019","unstructured":"Emral R, Aydo\u011fan B\u0130, K\u00f6se AD, Demir \u00d6, \u00c7orap\u00e7\u0131o\u011flu D (2019) Could a nonfunctional adrenal incidentaloma be a risk factor for increased carotid intima-media thickness and metabolic syndrome. Endocrinol Diabetes Nutr 66(7):402\u2013409","journal-title":"Endocrinol Diabetes Nutr"},{"issue":"2","key":"2679_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ando.2025.101687","volume":"86","author":"A Boyraz","year":"2025","unstructured":"Boyraz A, Candemir B, Ak\u0131n \u015e, Candemir M, G\u00fcl\u00e7elik NE (2025) Increased cardiovascular risk despite unchanged body composition in non functional adrenal incidentaloma. Ann Endocrinol (Paris) 86(2):101687","journal-title":"Ann Endocrinol (Paris)"},{"issue":"1","key":"2679_CR48","first-page":"57","volume":"125","author":"GB Cansu","year":"2017","unstructured":"Cansu GB, Sari R, Yilmaz N, \u00d6zdem S, \u00c7ubuk M (2017) Markers of subclinical cardiovascular disease in nonfunctional adrenal incidentaloma patients without traditional cardiovascular risk factors. Exp Clin Endocrinol Diab 125(1):57\u201363","journal-title":"Exp Clin Endocrinol Diab"},{"issue":"2","key":"2679_CR49","first-page":"292","volume":"9","author":"V Vasilev","year":"2014","unstructured":"Vasilev V, Matrozova J, Elenkova A, Zacharieva S (2014) Clinical characteristics and follow-up of incidentally found adrenal tumours - results from a single tertiary centre. Cent Eur J Med 9(2):292\u2013301","journal-title":"Cent Eur J Med"},{"issue":"4","key":"2679_CR50","doi-asserted-by":"publisher","first-page":"416","DOI":"10.5603\/EP.a2017.0034","volume":"68","author":"K Krzyzewska","year":"2017","unstructured":"Krzyzewska K, Niemczuk E, My\u015bliwiec BJ, Junik R (2017) Glucose metabolism disorders in patients with non-functioning adrenal adenomas - single-centre experience. Endokrynol Pol 68(4):416\u2013421","journal-title":"Endokrynol Pol"},{"issue":"10","key":"2679_CR51","doi-asserted-by":"publisher","first-page":"e77326","DOI":"10.1371\/journal.pone.0077326","volume":"8","author":"CH Anderwald","year":"2013","unstructured":"Anderwald CH, Tura A, Gessl A, Luger A, Pacini G, Krebs M (2013) Adequately adapted insulin secretion and decreased hepatic insulin extraction cause elevated insulin concentrations in insulin resistant non-diabetic adrenal incidentaloma patients. PLoS One 8(10):e77326","journal-title":"PLoS One"},{"issue":"4","key":"2679_CR52","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1111\/cen.13294","volume":"86","author":"L Papanastasiou","year":"2017","unstructured":"Papanastasiou L, Alexandraki K, Androulakis II, Fountoulakis S, Kounadi T, Markou A et al (2017) Concomitant alterations of metabolic parameters, cardiovascular risk factors and altered cortisol secretion in patients with adrenal incidentalomas during prolonged follow-up. Clin Endocrinol (Oxf) 86(4):488\u2013498","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"2679_CR53","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1111\/cen.13541","volume":"88","author":"LV Marina","year":"2018","unstructured":"Marina LV, Ivovi\u0107 M, Tan\u010di\u0107-Gaji\u0107 M, Arizanovi\u0107 Z, Rakovi\u0107 D, Milin-Lazovi\u0107 J et al (2018) Luteinizing hormone and insulin resistance in menopausal patients with adrenal incidentalomas: the cause\u2010effect relationship? Clin Endocrinol (Oxf) 88(4):541\u2013548","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2679_CR54","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ejim.2011.08.009","volume":"23","author":"S Yener","year":"2012","unstructured":"Yener S, C\u00f6mlekci A, Yuksel F, Sevinc A, Ertilav S, Yesil S (2012) Traditional and novel cardiovascular risk factors in non-functioning adrenal adenomas. Eur J Intern Med 23(1):83\u201387","journal-title":"Eur J Intern Med"},{"issue":"7","key":"2679_CR55","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s40618-018-0985-y","volume":"42","author":"AB Moraes","year":"2019","unstructured":"Moraes AB, Cavalari EMR, de Paula MP, Arruda M, Curi DSC, Leit\u00e3o RA et al (2019) Evaluation of body composition using dual-energy X-ray absorptiometry in patients with non-functioning adrenal incidentalomas and an intermediate phenotype: is there an association with metabolic syndrome? J Endocrinol Invest 42(7):797\u2013807","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"2679_CR56","first-page":"25","volume":"19","author":"AN Dagdemir","year":"2023","unstructured":"Dagdemir AN, Akalin A (2023) Lifestyle and anthropometric parameters in patients with nonfunctional adrenal incidentalomas. Acta Endocrinol (Copenh) 19(1):25\u201330","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"3","key":"2679_CR57","first-page":"323","volume":"67","author":"S Karatas","year":"2023","unstructured":"Karatas S, Hacioglu Y, Beysel S (2023) Metabolic syndrome and visceral adiposity index in non-functional adrenal adenomas. Arch Endocrinol Metab 67(3):323\u2013329","journal-title":"Arch Endocrinol Metab"},{"issue":"2","key":"2679_CR58","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1093\/ejendo\/lvae167","volume":"192","author":"JH Kim","year":"2025","unstructured":"Kim JH, Jang HN, Park SS, Yoon JH, Cho YM, Park SJ et al (2025) Body composition and cardiometabolic risks of patients with adrenal tumours in relation to hormonal activity: a large cross-sectional single-centre study. Eur J Endocrinol 192(2):141\u2013149","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2679_CR59","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s12020-021-02741-x","volume":"74","author":"F Athanasouli","year":"2021","unstructured":"Athanasouli F, Georgiopoulos G, Asonitis N, Petychaki F, Savelli A, Panou E et al (2021) Nonfunctional adrenal adenomas and impaired glucose metabolism: a systematic review and meta-analysis. Endocrine 74(1):50\u201360","journal-title":"Endocrine"},{"key":"2679_CR60","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-024-02440-0","author":"V Favero","year":"2024","unstructured":"Favero V, Parazzoli C, Bernasconi DP, Chiodini I (2024) Cardiometabolic comorbidities and cardiovascular events in non-functioning adrenal incidentalomas: a systematic review and meta-analysis. J Endocrinol Invest. https:\/\/doi.org\/10.1007\/s40618-024-02440-0","journal-title":"J Endocrinol Invest"},{"key":"2679_CR61","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-025-04170-6","author":"S Alkan","year":"2025","unstructured":"Alkan S, Guney SC, Akcura C, Ozdemir N, Hekimsoy Z (2025) Should adrenal incidentaloma patients be evaluated for muscle mass, function, and quality? A cross-sectional study. Endocrine. https:\/\/doi.org\/10.1007\/s12020-025-04170-6","journal-title":"Endocrine"},{"issue":"4","key":"2679_CR62","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1530\/EJE-20-1396","volume":"184","author":"D Li","year":"2021","unstructured":"Li D, Kaur RJ, Zhang CD, Ebbehoj A, Singh S, Atkinson EJ et al (2021) Risk of bone fractures after the diagnosis of adrenal adenomas: a population-based cohort study. Eur J Endocrinol 184(4):597\u2013606","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"2679_CR63","doi-asserted-by":"publisher","first-page":"bvae144","DOI":"10.1210\/jendso\/bvae144","volume":"8","author":"V Favero","year":"2024","unstructured":"Favero V, Cairoli E, Eller-Vainicher C, Morelli V, Salcuni AS, Casa S, Della et al (2024) Fragility fractures and cortisol secretion in patients with nonfunctioning adrenal incidentalomas. J Endocr Soc 8(10):bvae144","journal-title":"J Endocr Soc"},{"issue":"9","key":"2679_CR64","doi-asserted-by":"publisher","first-page":"E3307","DOI":"10.1210\/clinem\/dgaa410","volume":"105","author":"S Singh","year":"2020","unstructured":"Singh S, Atkinson EJ, Achenbach SJ, LeBrasseur N, Bancos I (2020) Frailty in patients with mild autonomous cortisol secretion is higher than in patients with nonfunctioning adrenal tumors. J Clin Endocrinol Metab 105(9):E3307\u2013E3315","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2679_CR65","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1093\/ejendo\/lvad113","volume":"189","author":"P Dogra","year":"2023","unstructured":"Dogra P, \u0160ambula L, Saini J, Thangamuthu K, Athimulam S, Delivanis DA et al (2023) High prevalence of frailty in patients with adrenal adenomas and adrenocortical hormone excess: a cross-sectional multi-centre study with prospective enrolment. Eur J Endocrinol 189(3):318\u2013326","journal-title":"Eur J Endocrinol"},{"key":"2679_CR66","doi-asserted-by":"publisher","first-page":"107","DOI":"10.7326\/M18-3630","volume":"171","author":"YS Elhassan","year":"2019","unstructured":"Elhassan YS, Alahdab F, Prete A, Delivanis DA, Khanna A, Prokop L et al (2019) Natural history of adrenal incidentalomas with and without mild autonomous cortisol excess. Ann Intern Med 171:107\u2013116","journal-title":"Ann Intern Med"},{"issue":"8","key":"2679_CR67","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1001\/jamainternmed.2023.2442","volume":"183","author":"J Patrova","year":"2023","unstructured":"Patrova J, Mannheimer B, Lindh JD, Falhammar H (2023) Mortality in patients with nonfunctional adrenal tumors. JAMA Intern Med 183(8):832\u2013838","journal-title":"JAMA Intern Med"},{"key":"2679_CR68","doi-asserted-by":"publisher","first-page":"e536","DOI":"10.1210\/clinem\/dgad074","volume":"108","author":"A Kjellbom","year":"2023","unstructured":"Kjellbom A, Lindgren O, Danielsson M, Olsen H, L\u00f6ndahl M (2023) Mortality not increased in patients with nonfunctional adrenal adenomas: a matched cohort study. J Clin Endocrinol Metab 108:e536\u2013e541","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2679_CR69","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1159\/000336589","volume":"21","author":"S Yener","year":"2012","unstructured":"Yener S, Ertilav S, Secil M, Akinci B, Demir T, Kebapcilar L et al (2012) Increased risk of unfavorable metabolic outcome during short-term follow-up in subjects with nonfunctioning adrenal adenomas. Med Princ Pract 21(5):429\u2013434","journal-title":"Med Princ Pract"},{"issue":"2","key":"2679_CR70","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1007\/s12020-022-03228-z","volume":"79","author":"M Araujo-Castro","year":"2023","unstructured":"Araujo-Castro M, Parra Ram\u00edrez P, Mart\u00edn Rojas-Marcos P, Garc\u00eda Centeno R, Gracia Gimeno P, Tom\u00e9 Fern\u00e1ndez-Ladreda M et al (2023) Nonfunctioning adrenal incidentalomas with cortisol post-dexamethasone suppression test\u2009>\u20090.9 \u00b5g\/dL have a higher prevalence of cardiovascular disease than those with values\u2009\u2264\u20090.9 \u00b5g\/dL. Endocrine 79(2):384\u2013391","journal-title":"Endocrine"},{"issue":"1","key":"2679_CR71","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-023-01836-1","volume":"22","author":"V Favero","year":"2023","unstructured":"Favero V, Aresta C, Parazzoli C, Cairoli E, Eller-Vainicher C, Palmieri S et al (2023) The degree of cortisol secretion is associated with diabetes mellitus and hypertension in patients with nonfunctioning adrenal tumors. Cardiovasc Diabetol 22(1):102","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"2679_CR72","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1210\/jc.2013-3527","volume":"99","author":"V Morelli","year":"2014","unstructured":"Morelli V, Reimondo G, Giordano R, Della Casa S, Policola C, Palmieri S et al (2014) Long-term follow-up in adrenal incidentalomas: an Italian multicenter study. J Clin Endocrinol Metab 99(3):827\u2013834","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2679_CR73","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1111\/cen.14745","volume":"97","author":"M Araujo-Castro","year":"2022","unstructured":"Araujo-Castro M (2022) Cardiometabolic profile and urinary metabolomic alterations in non-functioning adrenal incidentalomas: a review. Clin Endocrinol (Oxf) 97(6):693\u2013701","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2679_CR74","doi-asserted-by":"crossref","unstructured":"Araujo-Castro M, Pascual-Corrales E, Lamas C (2023) Possible, probable, and certain hypercortisolism: A continuum in the risk of comorbidity. Annales d\u2019Endocrinologie, vol 84. Elsevier Masson s.r.l., pp 272\u2013284","DOI":"10.1016\/j.ando.2023.01.005"},{"issue":"8","key":"2679_CR75","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvaa079","volume":"4","author":"C Eller-Vainicher","year":"2020","unstructured":"Eller-Vainicher C, Morelli V, Aresta C, Salcuni AS, Falchetti A, Carnevale V et al (2020) Defining nonfunctioning adrenal adenomas on the basis of the occurrence of hypocortisolism after adrenalectomy. J Endocr Soc 4(8):bvaa079","journal-title":"J Endocr Soc"},{"issue":"5","key":"2679_CR76","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.ando.2016.05.002","volume":"77","author":"V Raverot","year":"2016","unstructured":"Raverot V, Richet C, Morel Y, Raverot G, Borson-Chazot F (2016) Establishment of revised diagnostic cut-offs for adrenal laboratory investigation using the new Roche diagnostics Elecsys\u00ae cortisol II assay. Ann Endocrinol (Paris) 77(5):620\u2013622","journal-title":"Ann Endocrinol (Paris)"},{"issue":"3","key":"2679_CR77","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s42000-020-00185-y","volume":"19","author":"G Grassi","year":"2020","unstructured":"Grassi G, Morelli V, Ceriotti F, Polledri E, Fustinoni S, D\u2019Agostino S et al (2020) Minding the gap between cortisol levels measured with second-generation assays and current diagnostic thresholds for the diagnosis of adrenal insufficiency: a single-center experience. Hormones (Athens) 19(3):425\u2013431","journal-title":"Hormones (Athens)"},{"issue":"6","key":"2679_CR78","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1177\/00045632231179560","volume":"60","author":"JS Atkins","year":"2023","unstructured":"Atkins JS, Hawley JM, Owen LJ, Clayton J, Scargill J, Keevil BG (2023) Serum cortisol assay performance following the 1 mg overnight dexamethasone suppression test. Ann Clin Biochem 60(6):386\u2013395","journal-title":"Ann Clin Biochem"},{"key":"2679_CR79","doi-asserted-by":"publisher","DOI":"10.1093\/ejendo\/lvaf141","author":"L Rotolo","year":"2025","unstructured":"Rotolo L, Galante G, Coscia K, Bissi V, Tucci L, Mezzullo M et al (2025) Impact of old and current immunoassays on the 1 mg overnight dexamethasone suppression test: comparison with LC-MS\/MS. Eur J Endocrinol. https:\/\/doi.org\/10.1093\/ejendo\/lvaf141","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2679_CR80","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s12020-023-03429-0","volume":"82","author":"M Araujo-Castro","year":"2023","unstructured":"Araujo-Castro M, Hanzu FA, Pascual-Corrales E, Garc\u00eda Cano AM, Marchan M, Escobar-Morreale HF et al (2023) Is the 1\u00a0mg-dexamethasone suppression test a precise marker of glucocorticoid excess and cardiometabolic risk in patients with adrenal incidentalomas? Endocrine 82(1):161\u2013170","journal-title":"Endocrine"},{"issue":"11","key":"2679_CR81","first-page":"3141","volume":"26","author":"K Motohashi","year":"1968","unstructured":"Motohashi K, Osawa N, Yamaji T, Tanioka T, Ibayashi H (1968) Cushing syndrome. Nippon Rinsho 26(11):3141\u20133150","journal-title":"Nippon Rinsho"},{"issue":"3","key":"2679_CR82","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/s00223-004-0270-2","volume":"77","author":"RM Reynolds","year":"2005","unstructured":"Reynolds RM, Dennison EM, Walker BR, Syddall HE, Wood PJ, Andrew R et al (2005) Cortisol secretion and rate of bone loss in a population-based cohort of elderly men and women. Calcif Tissue Int 77(3):134\u2013138","journal-title":"Calcif Tissue Int"},{"issue":"5","key":"2679_CR83","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1530\/EJE-11-0957","volume":"166","author":"G Osella","year":"2012","unstructured":"Osella G, Ventura M, Ardito A, Allasino B, Termine A, Saba L et al (2012) Cortisol secretion, bone health, and bone loss: a cross-sectional and prospective study in normal nonosteoporotic women in the early postmenopausal period. Eur J Endocrinol 166(5):855\u2013860","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"2679_CR84","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1210\/jc.2016-3804","volume":"102","author":"EG Rodriguez","year":"2017","unstructured":"Rodriguez EG, Lamy O, Stoll D, Metzger M, Preisig M, Kuehner C et al (2017) High evening cortisol level is associated with low TBS and increased prevalent vertebral fractures: OsteoLaus study. J Clin Endocrinol Metab 102(7):2628\u20132636","journal-title":"J Clin Endocrinol Metab"},{"key":"2679_CR85","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.12659\/MSM.913532","volume":"25","author":"E Mazgelyt\u0117","year":"2019","unstructured":"Mazgelyt\u0117 E, Kar\u010diauskait\u0117 D, Linkevi\u010di\u016bt\u0117 A, Ma\u017eeikien\u0117 A, Burokien\u0117 N, Matuzevi\u010dien\u0117 R et al (2019) Association of hair cortisol concentration with prevalence of major cardiovascular risk factors and allostatic load. Med Sci Monit 25:3573\u20133582","journal-title":"Med Sci Monit"},{"issue":"6","key":"2679_CR86","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1530\/EC-19-0182","volume":"8","author":"AV Haas","year":"2019","unstructured":"Haas AV, Hopkins PN, Brown NJ, Pojoga LH, Williams JS, Adler GK et al (2019) Higher urinary cortisol levels associate with increased cardiovascular risk. Endocr Connect 8(6):634\u2013640","journal-title":"Endocr Connect"},{"issue":"4","key":"2679_CR87","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1530\/EJE-19-0161","volume":"181","author":"AA Crawford","year":"2019","unstructured":"Crawford AA, Soderberg S, Kirschbaum C, Murphy L, Eliasson M, Ebrahim S et al (2019) Morning plasma cortisol as a cardiovascular risk factor: findings from prospective cohort and Mendelian randomization studies. Eur J Endocrinol 181(4):429\u2013438","journal-title":"Eur J Endocrinol"},{"key":"2679_CR88","doi-asserted-by":"publisher","first-page":"427640","DOI":"10.1155\/2013\/427640","volume":"2013","author":"CG Schnackenberg","year":"2013","unstructured":"Schnackenberg CG, Costell MH, Krosky DJ, Cui J, Wu CW, Hong VS et al (2013) Chronic Inhibition of 11 \u03b2 -hydroxysteroid dehydrogenase type 1 activity decreases hypertension, insulin resistance, and hypertriglyceridemia in metabolic syndrome. Biomed Res Int 2013:427640","journal-title":"Biomed Res Int"},{"issue":"7","key":"2679_CR89","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.2337\/dc09-2315","volume":"33","author":"J Rosenstock","year":"2010","unstructured":"Rosenstock J, Banarer S, Fonseca VA, Inzucchi SE, William S, Wenqing Y et al (2010) The 11-\u03b2-hydroxysteroid dehydrogenase type 1 inhibitor INCB13739 improves hyperglycemia in patients with type 2 diabetes inadequately controlled by metformin monotherapy. Diabetes Care 33(7):1516\u20131522","journal-title":"Diabetes Care"},{"issue":"6","key":"2679_CR90","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1530\/EJE-16-0534","volume":"175","author":"VL Wester","year":"2016","unstructured":"Wester VL, Koper JW, Van Den Akker ELT, Franco OH, Stolk P, Van Rossum R (2016) Glucocorticoid receptor haplotype and metabolic syndrome: the lifelines cohort study. Eur J Endocrinol 175(6):645\u2013651","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"2679_CR91","doi-asserted-by":"publisher","DOI":"10.3390\/cells8101227","volume":"8","author":"B Liu","year":"2019","unstructured":"Liu B, Zhang TN, Knight JK, Goodwin JE (2019) The glucocorticoid receptor in cardiovascular health and disease. Cells 8(10):1227","journal-title":"Cells"},{"issue":"6","key":"2679_CR92","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.bone.2009.07.080","volume":"45","author":"JY Hwang","year":"2009","unstructured":"Hwang JY, Lee SH, Kim GS, Koh JM, Go MJ, Kim YJ et al (2009) HSD11B1 polymorphisms predicted bone mineral density and fracture risk in postmenopausal women without a clinically apparent hypercortisolemia. Bone 45(6):1098\u20131103","journal-title":"Bone"},{"issue":"4","key":"2679_CR93","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1210\/jc.2014-4177","volume":"100","author":"VV Zhukouskaya","year":"2015","unstructured":"Zhukouskaya VV, Eller-Vainicher C, Gaudio A, Cairoli E, Ulivieri FM, Palmieri S et al (2015) In postmenopausal female subjects with type 2 diabetes mellitus, vertebral fractures are independently associated with cortisol secretion and sensitivity. J Clin Endocrinol Metab 100(4):1417\u20131425","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2679_CR94","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s12020-020-02212-9","volume":"68","author":"V Morelli","year":"2020","unstructured":"Morelli V, Aresta C, Gaudio A, Eller-Vainicher C, Zhukouskaya VV, Merlotti D et al (2020) Prediction of hypertension, diabetes and fractures in eucortisolemic women by measuring parameters of cortisol milieu. Endocrine 68(2):411\u2013419","journal-title":"Endocrine"},{"issue":"5","key":"2679_CR95","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26052090","volume":"26","author":"A Andreadi","year":"2025","unstructured":"Andreadi A, Andreadi S, Todaro F, Ippoliti L, Bellia A, Magrini A et al (2025) Modified cortisol circadian rhythm: the hidden toll of night-shift work. Int J Mol Sci 26(5):2090","journal-title":"Int J Mol Sci"},{"key":"2679_CR96","doi-asserted-by":"publisher","first-page":"105462","DOI":"10.1016\/j.ebiom.2024.105462","volume":"110","author":"V Hasenmajer","year":"2024","unstructured":"Hasenmajer V, Sbardella E, Sciarra F, Simeoli C, Pivonello C, Ceccato F et al (2024) Circadian clock disruption impairs immune oscillation in chronic endogenous hypercortisolism: a multi-level analysis from a multicentre clinical trial. EBioMedicine 110:105462","journal-title":"EBioMedicine"},{"issue":"11","key":"2679_CR97","doi-asserted-by":"publisher","first-page":"4453","DOI":"10.1073\/pnas.0808180106","volume":"106","author":"FAJL Scheer","year":"2009","unstructured":"Scheer FAJL, Hilton MF, Mantzoros CS, Shea SA (2009) Adverse metabolic and cardiovascular consequences of circadian misalignment. Proc Natl Acad Sci U S A 106(11):4453\u20134458","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"2679_CR98","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvad087","volume":"7","author":"JW Findling","year":"2023","unstructured":"Findling JW, Raff H (2023) Recognition of nonneoplastic hypercortisolism in the evaluation of patients with Cushing syndrome. J Endocr Soc 7(8):bvad087","journal-title":"J Endocr Soc"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-025-02679-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-025-02679-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-025-02679-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T06:02:43Z","timestamp":1763791363000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-025-02679-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,26]]},"references-count":98,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2679"],"URL":"https:\/\/doi.org\/10.1007\/s40618-025-02679-1","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,26]]},"assertion":[{"value":"22 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest.\u00a0IC received consulting fees from Corcept Therapeutics and HRA Pharma.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Conflict of interest"}}]}}